相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The membrane protein KCNQ1 potassium ion channel: Functional diversity and current structural insights
Gunjan Dixit et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2020)
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Theo Vos et al.
LANCET (2020)
Cystatin C as an index of acute cerebral infraction recurrence: one-year follow-up study
Xiaoyu Dong et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2019)
Correlations of serum cystatin C level and gene polymorphism with vascular cognitive impairment after acute cerebral infarction
Qiong Zeng et al.
NEUROLOGICAL SCIENCES (2019)
Increased cortical infarction and neuroinflammation in ischemic stroke mice with experimental periodontitis
Li Chi et al.
NEUROREPORT (2019)
Neuroprotection mediated by cystatin C-loaded extracellular vesicles
Rocio Perez-Gonzalez et al.
SCIENTIFIC REPORTS (2019)
Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases
Hongxian Wu et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)
Association between Cystatin C and SVD in Chinese population
Huang Guoxiang et al.
NEUROLOGICAL SCIENCES (2018)
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017
Gregory A. Roth et al.
LANCET (2018)
Association between Serum Cystatin C and Vascular Complications in Type 2 Diabetes Mellitus without Nephropathy
Hye Jeong Kim et al.
DIABETES & METABOLISM JOURNAL (2018)
Cystatin C as a predictor of cardiovascular outcomes in a hypertensive population
R. Garcia-Carretero et al.
JOURNAL OF HUMAN HYPERTENSION (2017)
Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units
Jing Zou et al.
CELL DEATH & DISEASE (2017)
Global Burden of Stroke
Valery L. Feigin et al.
CIRCULATION RESEARCH (2017)
Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study
Anandita Agarwala et al.
ATHEROSCLEROSIS (2016)
Deletion of the N- or C-Terminal Helix of Apolipophorin Ill To Create a Four-Helix Bundle Protein
Pankaj Dwivedi et al.
BIOCHEMISTRY (2016)
Autophagy dysfunction and regulatory cystatin C in macrophage death of atherosclerosis
Wei Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
A new measure of between-studies heterogeneity in meta-analysis
Alessio Crippa et al.
STATISTICS IN MEDICINE (2016)
Cystatin C is an Independent Risk Factor and Therapeutic Target for Acute Ischemic Stroke
Bo Yang et al.
NEUROTOXICITY RESEARCH (2015)
How to understand the association between cystatin C levels and cardiovascular disease: Imbalance, counterbalance, or consequence?
Joao Victor Salgado et al.
JOURNAL OF CARDIOLOGY (2013)
Chronic kidney disease: global dimension and perspectives
Vivekanand Jha et al.
LANCET (2013)
Association between serum cystatin C, monocytes and other inflammatory markers
A. A. Evangelopoulos et al.
INTERNAL MEDICINE JOURNAL (2012)
Mechanism by which chronic kidney disease causes cardiovascular disease and the measures to manage this phenomenon
Eiji Kusano
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2011)
Cystatin C Deficiency Promotes Inflammation in Angiotensin II-Induced Abdominal Aortic Aneurisms in Atherosclerotic Mice
Stephanie Schulte et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Albuminuria and the risk of incident stroke and stroke types in older adults
M. I. Aguilar et al.
NEUROLOGY (2010)
Cystatin C and the Risk for Cardiovascular Events in Patients With Asymptomatic Carotid Atherosclerosis
Matthias Hoke et al.
STROKE (2010)
Low glomerular filtration rate and risk of stroke: meta-analysis
Meng Lee et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Chronic Kidney Disease and Clinical Outcome in Patients With Acute Stroke
Gilad Yahalom et al.
STROKE (2009)
Kidney dysfunction and fatal cardiovascular disease - an association independent of atherosclerotic events: Results from the Health, Aging, and Body Composition (Health ABC) study
Rajat Deo et al.
AMERICAN HEART JOURNAL (2008)
Differences in kidney function and incident hypertension: The multi-ethnic study of atherosclerosis
Bryan Kestenbaum et al.
ANNALS OF INTERNAL MEDICINE (2008)
Lipoprotein lipase: A bioinformatics criterion for assessment of mutations as a risk factor for cardiovascular disease
Sania Glisic et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2008)
Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease - Data from the Heart and Soul Study
Joachim H. Ix et al.
CIRCULATION (2007)
Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease
Michael G. Shlipak et al.
ANNALS OF INTERNAL MEDICINE (2006)
Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells
J Liu et al.
ATHEROSCLEROSIS (2006)
Neuronal cell death induced by cystatin C in vivo and in cultured human CNS neurons is inhibited with cathepsin B
A Nagai et al.
BRAIN RESEARCH (2005)
Cystatin C and incident peripheral arterial disease events in the elderly - Results from the cardiovascular health study
AM O'Hare et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
KCNQ1-dependent transport in renal and gastrointestinal epithelia
V Vallon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Expression of cystatin C prevents oxidative stress-induced death in PC 12 cells
K Nishiyama et al.
BRAIN RESEARCH BULLETIN (2005)
Relationship between aortic stiffening and microvascular disease in brain and kidney - Cause and logic of therapy
MF O'Rourke et al.
HYPERTENSION (2005)
Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events
M Loew et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Cystatin C and the risk of death and cardiovascular events among elderly persons
MG Shlipak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement
EL Knight et al.
KIDNEY INTERNATIONAL (2004)
Lysosomal cysteine proteases in atherosclerosis
JA Liu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Multi-ethnic study of atherosclerosis: Objectives and design
DE Bild et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency
CY Hsu et al.
KIDNEY INTERNATIONAL (2002)
Organelle-specific initiation of cell death pathways
KF Ferri et al.
NATURE CELL BIOLOGY (2001)
Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment
E Coll et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
分享论文
